PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.82B
Enterprise Value 3.00B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)20.12
Price/Book (mrq)4.24
Enterprise Value/Revenue 22.38
Enterprise Value/EBITDA -9.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.67
52-Week Change 3170.34%
S&P500 52-Week Change 33.90%
52 Week High 314.20
52 Week Low 33.85
50-Day Moving Average 311.40
200-Day Moving Average 39.27

Share Statistics

Avg Vol (3 month) 33.78M
Avg Vol (10 day) 34.03M
Shares Outstanding 5249.89M
Implied Shares Outstanding 6N/A
Float 8229.37M
% Held by Insiders 11.70%
% Held by Institutions 186.58%
Shares Short (May 14, 2023) 424.18M
Short Ratio (May 14, 2023) 47.51
Short % of Float (May 14, 2023) 410.81%
Short % of Shares Outstanding (May 14, 2023) 49.67%
Shares Short (prior month Apr 13, 2023) 427.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -239.32%
Operating Margin (ttm)-224.97%

Management Effectiveness

Return on Assets (ttm)-9.83%
Return on Equity (ttm)-44.97%

Income Statement

Revenue (ttm)134.03M
Revenue Per Share (ttm)0.58
Quarterly Revenue Growth (yoy)17.30%
Gross Profit (ttm)53.47M
EBITDA -290.64M
Net Income Avi to Common (ttm)-320.76M
Diluted EPS (ttm)-1.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)874.89M
Total Cash Per Share (mrq)3.5
Total Debt (mrq)946.73M
Total Debt/Equity (mrq)136.79
Current Ratio (mrq)3.69
Book Value Per Share (mrq)2.77

Cash Flow Statement

Operating Cash Flow (ttm)-278.87M
Levered Free Cash Flow (ttm)39.74M